STERIS ROE 2010-2024 | STE
Current and historical return on equity (ROE) values for STERIS (STE) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| STERIS ROE - Return on Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Shareholder's Equity | Return on Equity |
| 2024-03-31 | $0.38B | $6.32B | 6.04% |
| 2023-12-31 | $0.57B | $6.43B | 9.12% |
| 2023-09-30 | $0.55B | $6.19B | 8.98% |
| 2023-06-30 | $0.12B | $6.18B | 1.99% |
| 2023-03-31 | $0.11B | $6.09B | 1.76% |
| 2022-12-31 | $-0.03B | $6.05B | -0.45% |
| 2022-09-30 | $-0.01B | $5.81B | -0.13% |
| 2022-06-30 | $0.38B | $6.42B | 5.77% |
| 2022-03-31 | $0.24B | $6.55B | 3.71% |
| 2021-12-31 | $0.28B | $6.62B | 4.72% |
| 2021-09-30 | $0.25B | $6.55B | 4.78% |
| 2021-06-30 | $0.29B | $6.59B | 6.35% |
| 2021-03-31 | $0.40B | $3.89B | 10.67% |
| 2020-12-31 | $0.43B | $3.88B | 12.02% |
| 2020-09-30 | $0.42B | $3.66B | 12.14% |
| 2020-06-30 | $0.41B | $3.49B | 12.20% |
| 2020-03-31 | $0.41B | $3.42B | 12.27% |
| 2019-12-31 | $0.39B | $3.40B | 12.03% |
| 2019-09-30 | $0.34B | $3.24B | 10.52% |
| 2019-06-30 | $0.32B | $3.25B | 10.04% |
| 2019-03-31 | $0.30B | $3.19B | 9.68% |
| 2018-12-31 | $0.27B | $3.11B | 8.57% |
| 2018-09-30 | $0.32B | $3.13B | 10.06% |
| 2018-06-30 | $0.30B | $3.10B | 9.72% |
| 2018-03-31 | $0.29B | $3.22B | 9.45% |
| 2017-12-31 | $0.24B | $3.12B | 8.16% |
| 2017-09-30 | $0.14B | $3.04B | 4.95% |
| 2017-06-30 | $0.12B | $2.94B | 4.13% |
| 2017-03-31 | $0.11B | $2.81B | 3.75% |
| 2016-12-31 | $0.14B | $2.77B | 4.75% |
| 2016-09-30 | $0.17B | $3.01B | 5.49% |
| 2016-06-30 | $0.14B | $3.05B | 5.31% |
| 2016-03-31 | $0.11B | $3.04B | 5.40% |
| 2015-12-31 | $0.09B | $2.99B | 6.01% |
| 2015-09-30 | $0.11B | $1.09B | 10.32% |
| 2015-06-30 | $0.13B | $1.10B | 12.41% |
| 2015-03-31 | $0.14B | $1.07B | 12.61% |
| 2014-12-31 | $0.13B | $1.08B | 12.51% |
| 2014-09-30 | $0.12B | $1.07B | 11.85% |
| 2014-06-30 | $0.12B | $1.07B | 11.98% |
| 2014-03-31 | $0.13B | $1.04B | 12.96% |
| 2013-12-31 | $0.13B | $1.01B | 13.47% |
| 2013-09-30 | $0.15B | $0.99B | 15.77% |
| 2013-06-30 | $0.16B | $0.97B | 17.31% |
| 2013-03-31 | $0.16B | $0.95B | 17.76% |
| 2012-12-31 | $0.16B | $0.92B | 18.74% |
| 2012-09-30 | $0.15B | $0.88B | 17.84% |
| 2012-06-30 | $0.14B | $0.83B | 17.18% |
| 2012-03-31 | $0.14B | $0.82B | 17.15% |
| 2011-12-31 | $0.13B | $0.78B | 16.70% |
| 2011-09-30 | $0.12B | $0.78B | 15.32% |
| 2011-06-30 | $0.13B | $0.82B | 16.33% |
| 2011-03-31 | $0.05B | $0.79B | 7.01% |
| 2010-12-31 | $0.04B | $0.75B | 5.87% |
| 2010-09-30 | $0.06B | $0.73B | 8.51% |
| 2010-06-30 | $0.06B | $0.70B | 7.77% |
| 2010-03-31 | $0.13B | $0.75B | 16.91% |
| 2009-12-31 | $0.13B | $0.73B | 16.84% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $22.495B | $5.139B |
| STERIS plc, develops, manufactures and markets infection prevention, decontamination, microbial reduction, and surgical and gastrointestinal support products and services. On Nov 2, 2015, STERIS completed the acquisition of Synergy Health plc following which it was re-registered under the name ' STERIS plc. Currently, STERIS serves healthcare, pharmaceutical, research, industrial and governmental customers across the globe. The majority of STERIS' revenues is derived from the healthcare and pharmaceutical industries. STERIS provides its products and services in more than 60 countries. The company's key areas of strategic focus include developing its customer base in Europe, the Middle East and the Asia Pacific region. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $226.930B | 27.22 |
| Intuitive Surgical (ISRG) | United States | $155.197B | 87.88 |
| Alcon (ALC) | Switzerland | $45.300B | 32.45 |
| DexCom (DXCM) | United States | $42.890B | 61.63 |
| IQVIA Holdings (IQV) | United States | $42.346B | 24.00 |
| IDEXX Laboratories (IDXX) | United States | $38.872B | 45.56 |
| Edwards Lifesciences (EW) | United States | $35.975B | 23.05 |
| Waters (WAT) | United States | $18.406B | 27.05 |
| Hologic (HOLX) | United States | $18.175B | 20.33 |
| SONOVA HOLDING (SONVY) | Switzerland | $17.783B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $11.965B | 13.97 |
| Teleflex (TFX) | United States | $10.480B | 16.31 |
| Sysmex ADR (SSMXY) | Japan | $9.774B | 30.65 |
| Globus Medical (GMED) | United States | $9.713B | 28.47 |
| Penumbra (PEN) | United States | $7.369B | 83.74 |
| Glaukos (GKOS) | United States | $5.926B | 0.00 |
| Masimo (MASI) | United States | $5.838B | 33.57 |
| TransMedics (TMDX) | United States | $4.809B | 456.22 |
| Integer Holdings (ITGR) | United States | $3.876B | 22.68 |
| PROCEPT BioRobotics (PRCT) | United States | $3.312B | 0.00 |
| Inari Medical (NARI) | United States | $3.209B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.894B | 17.19 |
| Tandem Diabetes Care (TNDM) | United States | $2.626B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $2.485B | 10.84 |
| Veracyte (VCYT) | United States | $1.816B | 0.00 |
| RxSight (RXST) | United States | $1.676B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $1.521B | 0.00 |
| Artivion (AORT) | United States | $1.145B | 109.84 |
| Pulse Biosciences (PLSE) | United States | $1.084B | 0.00 |
| Silk Road Medical (SILK) | United States | $1.065B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $1.052B | 20.46 |
| OPKO Health (OPK) | United States | $0.990B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.783B | 0.00 |
| Paragon 28 (FNA) | United States | $0.718B | 0.00 |
| SiBone (SIBN) | United States | $0.658B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.620B | 0.00 |
| IRadimed (IRMD) | United States | $0.598B | 33.51 |
| Mesa Laboratories (MLAB) | United States | $0.585B | 17.31 |
| Pacific Biosciences Of California (PACB) | United States | $0.519B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.486B | 0.00 |
| AxoGen (AXGN) | United States | $0.408B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.400B | 0.00 |
| Nevro (NVRO) | United States | $0.363B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.307B | 10.50 |
| AngioDynamics (ANGO) | United States | $0.301B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.242B | 0.00 |
| NeuroPace (NPCE) | United States | $0.234B | 0.00 |
| Inogen (INGN) | United States | $0.229B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.227B | 11.52 |
| ClearPoint Neuro (CLPT) | United States | $0.207B | 0.00 |
| CVRx (CVRX) | United States | $0.206B | 0.00 |
| 908 Devices (MASS) | United States | $0.191B | 0.00 |
| Accuray (ARAY) | United States | $0.186B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.177B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.174B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.147B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.114B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.104B | 21.86 |
| Spectral Diagnostics (EDTXF) | Canada | $0.103B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.084B | 0.00 |
| Hyperfine (HYPR) | United States | $0.083B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.079B | 0.00 |
| InspireMD (NSPR) | Israel | $0.074B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.073B | 0.00 |
| LENSAR (LNSR) | United States | $0.061B | 0.00 |
| Neuronetics (STIM) | United States | $0.057B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.045B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.045B | 0.00 |
| Envoy Medical (COCH) | United States | $0.042B | 0.00 |
| Precision Optics (POCI) | United States | $0.039B | 0.00 |
| DarioHealth (DRIO) | United States | $0.035B | 0.00 |
| ReWalk Robotics (LFWD) | Israel | $0.033B | 0.00 |
| Spectral AI (MDAI) | United States | $0.031B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.029B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.027B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.024B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.022B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.021B | 0.00 |
| Pixie Dust Technologies (PXDT) | Japan | $0.019B | 0.00 |
| NexGel (NXGL) | United States | $0.017B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.016B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.014B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.013B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.012B | 0.00 |
| PAVmed (PAVM) | United States | $0.010B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.006B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.003B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.003B | 0.00 |
| Avinger (AVGR) | United States | $0.003B | 0.00 |
| Tenon Medical (TNON) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.001B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |